Clorox reported a decline in net sales by 8% to $1.7 billion, driven by a 10-point decline in volume, though favorable price mix contributed 2 points. Gross margin decreased significantly by 1240 basis points to 33%. Diluted EPS decreased by 72% to $0.56, and adjusted EPS declined by 67% to $0.66.
Net sales decreased by 8% to $1.7 billion, reflecting a 10-point decline in volume and 2 points of favorable price mix.
Gross margin decreased to 33% from 45% due to higher manufacturing & logistics and commodity costs.
Diluted EPS decreased by 72% to $0.56, primarily driven by lower gross margin and lower net sales.
Adjusted EPS decreased by 67% to $0.66, excluding investments in long-term strategic digital capabilities and productivity enhancements.
The company updated its fiscal year 2022 outlook, projecting a net sales decline of 1% to 4% and diluted EPS between $3.80 and $4.05.
Visualization of income flow from segment revenue to net income